The quantification of helper T cells (CD3+CD4+), cytotoxic T cells (CD3+CD8+), B cells (CD19+CD3neg), monocytes (CD45+CD14+) and NK cells (CD16+/CD56+CD3neg) revealed no significant differences between patients with breast cancer and healthy controls (data not shown). This evidence concerns the gene CD19 and breast cancer.